Drug Discovery World

FEBRUARY 8, 2024

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. For the AAV packaging service, what is the titer of the viral particles? Dr O’Hara also provided an AAV plasmid preparation case study. Why are those important?

Gene Therapy 59

Gene Therapy Gene Bioinformatics Life Science 59

BioSpace

FEBRUARY 3, 2021

From packaging errors and contaminants to serious adverse effects, there are many reasons why products in the life sciences industry get recalled. Here’s a look at some of the latest drug and medical device recalls.

Contamination 79

Contamination Life Science Packaging Packaging 79

XTalks

DECEMBER 14, 2020

AvKARE, a generics pharmaceutical manufacturer based in Pulaski, Tennessee, has issued a recall on one lot each of its sildenafil 100 mg tablets and trazodone 100 mg tablets due to a packaging “mix-up” in which both drugs were filled into the same bottle. According to AvKARE, the error occurred at a third-party bottle filling facility.

Packaging 98

Packaging Packaging Drugs Generic Pharmaceutical 98

Drug Discovery World

OCTOBER 3, 2023

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. For the AAV packaging service, what is the titer of the viral particles? Dr O’Hara also provided an AAV plasmid preparation case study.

Gene Therapy 52

Gene Therapy Gene Life Science Bioinformatics 52

Pharma in Brief

NOVEMBER 20, 2023

In recent months, the Federal Courts have twice upheld Health Canada’s findings as to what is, and is not, a natural health product. The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations.

Production 52

Production Cosmetics Regulation Branding 52

Drug Discovery World

JULY 5, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

JUNE 29, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

JUNE 22, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Pharmaceutical Technology

MAY 26, 2023

PWC predicts deal volumes to resemble prior years with the effect of the US Inflation Reduction Act on pricing better understood and less uncertainty surrounding business conditions, according to an article entitled Pharmaceutical & Life Sciences: US Deals 2023 Outlook published on the company’s website. Catalent Inc.

Life Science 130

Life Science Manufacturing Contract Manufacturing Gene Therapy 130

XTalks

MAY 27, 2021

To help boost production of its COVID-19 vaccine, Moderna has enlisted the services of Samsung Biologics , a contract development and manufacturing organization (CDMO) based in South Korea. As its first and only approved product, the decade-old company did not have capacities for mass production at its lone US plant in Massachusetts.

Manufacturing 98

Manufacturing Production Vaccination Vaccine 98

XTalks

DECEMBER 14, 2020

AvKARE, a generics pharmaceutical manufacturer based in Pulaski, Tennessee, has issued a recall on one lot each of its sildenafil 100 mg tablets and trazodone 100 mg tablets due to a packaging “mix-up” in which both drugs were filled into the same bottle. According to AvKARE, the error occurred at a third-party bottle filling facility.

Packaging 52

Packaging Packaging Drugs Generic Pharmaceutical 52

Pharma in Brief

AUGUST 3, 2023

On July 31, 2023, Health Canada published its updated Guidance on distinction between advertising and other activities for health products (the Distinction Guidance ). What influence does a health product manufacturer have on the message? Links: Guidance on distinction between advertising and other activities for health products

Production 52

Production Drugs Manufacturing Clinical Trials 52

pharmaphorum

OCTOBER 13, 2021

This is an exciting opportunity to join pharmaphorum, contributing to our revenue targets, meeting new clients and supporting the development and launch of new offerings within the company’s leading international life science industry publications. Duties and responsibilities. Follow up on leads generated by other members of the team.

Sales 98

Sales Life Science Packaging Packaging 98

pharmaphorum

JANUARY 27, 2021

A plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today after it was sent a suspicious package. Wockhardt UK in Wrexham this morning received a suspicious package. There are no reports of any injuries and as yet no word whether the package was dangerous.

Vaccination 98

Vaccination Vaccine Packaging Packaging 98

XTalks

JULY 20, 2022

The production facility will be equipped to develop and manufacture plasmid DNA, nucleic acids, recombinant proteins and other therapeutics produced through methods involving microbial fermentation. Additionally, the site will be able to prepare and package 70 million fill and finish vaccine doses per year for commercial distribution.

Vaccination 105

Vaccination Vaccine Manufacturing Life Science 105

pharmaphorum

JANUARY 4, 2022

Provided as a cloud or on-premise solution, PRISYM 360 is designed specifically to address the unique complexities of medical device, clinical trial and pharmaceutical labeling and packaging artwork. About PRISYM ID. Media Contact: Andrew Baud, Distil,? andrew@teamdistil.com , +44 (0) 7775 715775.

Life Science 52

Life Science Clinical Trials Clinical Trials Compliance 52

XTalks

NOVEMBER 23, 2021

The investment will go towards expanding Biovectra’s existing production facility in Charlottetown, the capital of PEI. Additional production would be performed at other facilities for final packaging. Additional production would be performed at other facilities for final packaging.

Manufacturing 98

Manufacturing Vaccination Vaccine Drugs 98

The Pharma Data

OCTOBER 26, 2020

Under the terms of the agreement, Novasep will be in charge of developing and manufacturing (cell culture, AAV expression, purification, aseptic distribution and quality control) the two AAV vectors designed for the Sensorion OTOF-GT project and will supply Drug Product batches to support preclinical and clinical studies.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

Drug Discovery World

FEBRUARY 10, 2023

Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

XTalks

APRIL 2, 2024

For example, Proctor & Gamble was found to emit almost five times more CO 2 e than Johnson & Johnson despite the two companies having similar revenue levels and producing similar lines of products. Similarly, Eli Lilly’s emissions were 5.5 times greater than Roche’s in 2015. Eisai Eisai Co., as of March 24, 2024.

Pharma Companies 102

Pharma Companies Packaging Packaging Production 102

pharmaphorum

MARCH 10, 2022

Biologics product development has increased steadily over the past decade, with the volume of business forecast to double by 2030. Driven by advancements in technology, these complex therapeutics have already made waves in life sciences, providing revolutionary treatment options in oncology, immune conditions and rare diseases.

Production 98

Production Life Science Development Gene Therapy 98

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Automation can be such a solution. Reducing capacity issues. Cutting down on safety stock.

Production 106

Production Manufacturing Drugs Marketing 106

XTalks

MARCH 25, 2021

She focuses on news relating to the food industry and writes blogs on recruitment and HR in the life sciences. Ayesha Rashid, PhD , is a senior life science journalist and webinar moderator at Xtalks where she covers the latest news stories in the industry.

Life Science 95

Life Science HR Branding Production 95

pharmaphorum

FEBRUARY 10, 2021

It will develop 11 solutions using state-of-the-art computational technologies to test the safety and/or the efficacy of medical devices, medicinal products, and even advanced therapy medicinal products such as tissue engineering constructs for regenerative medicine.

Development 76

Development Drugs Medicine Life Science 76

pharmaphorum

OCTOBER 27, 2022

The Guidance applies to both product-related and therapeutic-area-related activities. In the EU and UK, where direct-to-consumer promotion of POMs is prohibited, companies may not sponsor blogs that promote, or could reasonably be expected to promote, such products. Digital Channels include, but are not limited to, social media ”.

Life Science 98

Life Science Compliance Regulation Cosmetics 98

pharmaphorum

MARCH 3, 2022

The UK biopharma industry has welcomed a new tranche of funding from the government aimed at bolstering manufacturing of medicinal products and developing the national health data infrastructure.

Manufacturing 52

Manufacturing Life Science Clinical Trials Clinical Trials 52

pharmaphorum

MAY 27, 2022

As the shift to home working proliferated during the pandemic, work became decentralised – and many businesses were able to be productive with a workforce at home. Underrepresentation is multifactorial, so concerted efforts from life science companies are required to address inequitable healthcare. About the interviewees.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

Drug Discovery World

AUGUST 4, 2022

This is especially true now, with the rise of drug-device combination products that demand sophisticated delivery systems. The increasing complexity of drug products has raised concern among pharmaceutical developers. However, starting early can greatly improve the efficiency and speed of the development process. Testing compatibility.

Containment 52

Containment Development Drugs Production 52

XTalks

MAY 28, 2024

A deep dive into the list reveals that the formula for a high level of employee satisfaction is a mix of competitive financial packages, benefits such as healthcare, education support and professional development, wellness initiatives, recognitions for achievements and diversity and inclusion.

Manufacturing 52

Manufacturing Life Science Packaging Packaging 52

pharmaphorum

JULY 13, 2021

“Whether it is a medical device company coming to terms with regulatory changes or a clinical trial organization adapting to the new world of decentralized trials, we want our customer to feel that they can call upon our expertise at any time to help them get the most out of the products we offer. For more information:?? .

Clinical Trials 52

Clinical Trials Clinical Trials Compliance Trials 52

Drug Discovery World

MAY 1, 2023

Key elements of the proposal Better access to medicines New incentives are designed to encourage companies to make their medicines available to patients in all EU countries and develop products that address unmet medical needs.

Medicine 52

Medicine Packaging Packaging Production 52

XTalks

JANUARY 24, 2022

The seized counterfeit drugs had falsified paperwork and, in some cases, also had altered packaging. The safety of individuals taking Gilead medication is always our first priority,” said Merdad Parsey, MD, PhD, chief medical officer, Gilead Sciences, in the press release. “We While Biktarvy brought in $7.3

Drugs 98

Drugs Pharmacy Containment Production 98

The Pharma Data

NOVEMBER 30, 2020

I n-licensing of four clinical-stage product candidates to treat orphan neurological disorders. Financing will advance the development of four clinical – stage product candidates. Highly experienced team leverages latest scientific discoveries in neuroscience. BASEL, Switzerland, Dec.

Life Science 40

Life Science Licensing Licensing Production 40

pharmaphorum

DECEMBER 9, 2021

After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.

Allergies 106

Allergies Life Science Development Scientist 106

The Pharma Data

AUGUST 7, 2020

Most importantly, we are continuing to see patients benefit from the profound therapeutic effects of both approved products and those currently in clinical development. We are committed to bringing these life-changing therapies to patients in need,” Lambert added.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Trials 52

Drug Discovery World

JANUARY 10, 2023

For over 50 years, Bethyl Laboratories (now a Fortis Life Sciences brand) has been dedicated to improving lives by supporting scientific discovery through qualified antibody products and custom services. We are vertically-integrated from immunisation through manufacturing and validation. Our areas of expertise.

Antibody 52

Antibody Protein Reagent Scientist 52

Pharma in Brief

MARCH 18, 2021

The intent of the draft guidance document is to describe Health Canada’s expectations for manufacturers who distribute prescription drug information through an electronic means, such as a website or mobile app, that is directly linked to a product’s packaging or label. Background and scope. Guidelines for electronic labelling.

Drugs 40

Drugs Packaging Packaging Containment 40